v3.25.1
Condensed Consolidated Statements Of Cash Flows (Statement) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 58,965 $ 45,851
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 36,201 35,351
Other non-operating losses 217 0
Amortization of deferred financing costs and debt discounts 1,237 1,428
Deferred income taxes (1,940) 319
Equity-based compensation 9,263 512
(Income) loss from non-consolidated affiliates (1,229) 1,317
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:    
Accounts receivable (30,717) 60,333
Inventories (5,192) (453)
Prepaid expenses and other current assets 36,049 5,577
Accounts payable and other accrued expenses and liabilities (46,695) (115,779)
Accrued salaries and benefits (80,946) (49,145)
Net cash used in operating activities (24,787) (14,689)
Cash flows from investing activities:    
Investment in acquisitions, net of cash acquired 0 (7,800)
Purchases of property and equipment (22,908) (23,838)
Other (214) 0
Net cash used in investing activities (23,122) (31,638)
Cash flows from financing activities:    
Proceeds from insurance financing arrangements 10,959 0
Proceeds from long-term debt 0 951
Payments of principal on insurance financing arrangements (3,104) (1,630)
Payments of principal on long-term debt (1,387) (3,549)
Distributions to noncontrolling interests (19,239) (14,256)
Other (1,061) 0
Net cash used in financing activities (13,832) (18,484)
Net decrease in cash and cash equivalents (61,741) (64,811)
Cash and cash equivalents at beginning of period 556,785 437,577
Cash and cash equivalents at end of period 495,044 372,766
Supplemental Cash Flow Information:    
Non-cash purchases of property and equipment $ 6,662 $ 1,194